All blog posts
Total 57 results for
Showing 24 out of 57 results
11 November 2020
Consultation on MHRA draft guidance on the licensing of biosimilar products post transition – open until 15 November 2020
23 September 2020
The Italian medicines agency AIFA opens a public consultation on the draft guidelines for the preparation of the dossier supporting a price and reimbursement application
17 September 2020
Glaxo’s purple inhalers fail to get trade mark protection
11 September 2020
The Unified Patent Court - on the move again?
17 August 2020
Patent and Pharma Update, August 2020
24 July 2020
Judicial Review – Strategies for Pharmaceutical Companies
In the latest episode of HSF's webinar series on the pharmaceutical sector, Andrew Lidbetter, Sanam Zulfiqar Khan, Mark Smyth and Lourdes Fraguas discuss …
21 July 2020
UK's exit from the UPC now final
15 July 2020
Where is the balance now? Preliminary injunctions in pharmaceutical patent proceedings in 2020 and beyond
Recent decisions of the Federal Court of Australia have significantly changed the way in which parties to pharmaceutical patent litigation should analyse …
02 July 2020
The High Court of England & Wales maintains the status quo for Edwards’ PASCAL Transcatheter Valve Repair System when considering a stay of a final injunction pending appeal
26 June 2020
Court of Appeal of England & Wales maintains no interim injunction for Neurim and Flynn against generic Circadin® – damages held to be an adequate remedy
25 June 2020
CJEU rules that providing free samples of non-prescription drugs to pharmacists is permitted
24 June 2020
UK Supreme Court in Regeneron v Kymab: technical contribution critical to determining sufficiency
Showing 24 out of 57 results
View more